MCT1 has a greater affinity for pyruvate and is the main transmembrane transporter for hyperpolarized [1–13C]pyruvate, which has been shown to be rate limiting for hyperpolarized [1–13C]lactate formation in some breast cancer cell lines and can account for treatment-induced changes (19, 36). Here, SLC16A1 is linked to breast cancer.